All Report
Whether you’re exploring new opportunities, responding to change, or planning your next move—we’re here to help you make sense of it all. Our research goes beyond data to uncover real market signals, emerging trends, competitive shifts, and what they mean for your business. With practical insights and a partner mindset, we support you in making smarter, faster, and more confident decisions.
The global intraoperative fluorescence imaging market is projected to witness rapid growth, expanding from USD 606.8 million in 2025 to USD 2.8 billion by 2035, at a CAGR of 12.9% over the forecast period.
The global intraoperative radiation therapy (IORT) systems market is poised for substantial growth, with a projected valuation increasing from USD60.3 million in 2024 to USD125.7 million by 2034, driven by a robust CAGR of 8.7% during the forecast period.
The global Intraoral IOL Scanner Market is poised for significant growth, with projections estimating a CAGR of 11.7% from 2025 to 2035.
The global intraoral scanners market is expected to witness remarkable growth, increasing from USD 745.7 million in 2025 to USD 1,949.0 million by 2035, registering a CAGR of 8.6% during the forecast period.
The global Intraosseous Devices Market is on a steady growth trajectory, with projections estimating a CAGR of 6.8% from 2025 to 2035.
The global intraosseous infusion devices market is projected to experience robust growth, increasing from USD 5.07 billion in 2025 to USD 10.46 billion by 2035, expanding at a CAGR of 7.5% over the forecast period.
The global intravascular imaging market is projected to witness substantial growth, with an estimated valuation of USD 388.8 million in 2025, expanding to approximately USd 657.29 million by 2035.
The global intravenous iron drugs market is forecasted to reach USD 3.8 billion in 2025 and expand to USD 7.3 billion by 2035.
The global intrauterine insemination (IUI) devices market is projected to reach a valuation of USD 41.5 million in 2025 and expand to USD 58.5 million by 2035.
The global Intratumoral Cancer Therapies Market is poised for significant growth, projected to achieve a valuation of USD 213.96 billion by 2024, expanding at a robust CAGR of 11% to reach approximately USD 553.36 billion by 2034